Header cover image

Chinese Pharmaceuticals & Biotech Your first investment

Results

9

0 new
Based on available information up to March 12, 2025, Donald Trump’s plans for oil and gas focus on maximizing U.S. production, reducing regulatory barriers, and prioritizing fossil fuels as a cornerstone of his energy policy. Here’s a concise overview of his intentions: Boost Production and Permitting: Trump has pledged to "unleash" American oil and gas by accelerating permitting processes. On his first day in office (January 20, 2025), he signed executive orders declaring a "national energy emergency" to fast-track approvals for energy infrastructure like pipelines, refineries, and power plants. This includes expanding drilling on federal lands and offshore areas, reversing Biden-era restrictions.

9 companies

Yunnan Baiyao GroupLtd

Market Cap: CN¥88.8b

Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.

000538

CN¥49.75

7D

-1.6%

1Y

-12.6%

Zhangzhou Pientzehuang Pharmaceutical

Market Cap: CN¥76.8b

Manufactures and distributes pharmaceuticals and cosmetics in China and internationally.

600436

CN¥127.30

7D

-5.8%

1Y

-38.7%

China Resources Sanjiu Medical & Pharmaceutical

Market Cap: CN¥41.0b

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

000999

CN¥24.61

7D

-1.4%

1Y

-18.9%

Dong-E-E-Jiao

Market Cap: CN¥33.0b

Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.

000423

CN¥51.74

7D

-2.3%

1Y

1.8%

Beijing Tongrentang

Market Cap: CN¥33.0b

Engages in the production and sale of traditional Chinese medicine preparations in China and internationally.

600085

CN¥24.06

7D

-3.3%

1Y

-34.6%

Apeloa PharmaceuticalLtd

Market Cap: CN¥24.9b

Provides raw materials various pharmaceutical factories in the People’s Republic of China and internationally.

000739

CN¥22.09

7D

-1.1%

1Y

35.3%

Livzon Pharmaceutical Group

Market Cap: CN¥23.9b

Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People’s Republic of China and internationally.

000513

CN¥29.72

7D

-2.9%

1Y

-26.6%

Tasly Pharmaceutical Group

Market Cap: CN¥22.8b

Engages in the research, development, production, and sale of pharmaceuticals in China.

600535

CN¥15.24

7D

-0.5%

1Y

-12.5%

Tonghua Dongbao Pharmaceutical

Market Cap: CN¥16.1b

Engages in the research, development, production, and sale of biological products, traditional Chinese medicines, chemical medicines, and other drugs in China and internationally.

600867

CN¥8.24

7D

-1.8%

1Y

-2.8%